Anti-Saccharomyces cerevisiae manna antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: Prevalence and diagnostic role

Gut

Volumn 42, Issue 6, 1998, Pages 788-791

  Quinton, J F ^a   Sendid, B ^b   Reumaux, D ^d   Duthilleul, P ^d   Cortot, A ^a   Grandbastien, B ^c   Charrier, G ^a   Targan, S R ^e   Colombel, J F ^a,f   Poulain, D ^b  

^a Serv d'Hépato Gastroenterol

^b Lab de Parasitologie Mycologie

^c UNIV LILLE   (France)

^d CH Valenciennes ^*  (France)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

Anti Saccharomyces cerevisiae mannan antibodies; Antineutrophil cytoplasmic autoantibodies; Crohn's disease; Ulcerative colitis

Indexed keywords

AUTOANTIBODY; MANNAN; NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ANTIBODY DETECTION; ARTICLE; CROHN DISEASE; DIAGNOSTIC VALUE; DISEASE MARKER; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN DETERMINATION; SACCHAROMYCES CEREVISIAE; ULCERATIVE COLITIS;

EID: 7144255517     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.42.6.788     Document Type: Article

References (28)

1. Gower-Rousseau C, Salomez JL, Dupas JL, et al. Incidence of inflammatory bowel disease in northern France (1988-1990). Gut 1994;35:1433-8.
2. Sandler RS. Epidemiology of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease. From bench to bedside. Baltimore: Williams and Wilkins, 1993:5-30.
3. Saxon A, Shanahan F, Landers C, et al. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. J Allergy Clin Immunol 1990;86:202-10.
4. Rump JA, Schölmerich J, Gross V, et al. A new type of perinuclear antineutrophil cytoplasmic antibody (p-ANCA) in active ulcerative colitis but not in Crohn's disease. Immunobiology 1990;181:406-13.
5. Duerr RH, Targan SR, Landers CJ, et al. Anti-neutrophil cytoplasmic antibodies in ulcerative colitis: comparison with other colitides/diarrheal illnesses. Gastroenterology 1991;100:1590-6.
6. Colombel JF, Reumaux D, Duthilleul P, et al. Antineutrophil cytoplasmic autoantibodies in inflammatory bowel diseases. Gastroenterol Clin Biol 1992;16:656-60.
7. Cambridge G, Rampton DS, Stevens TRJ, et al. Antineutrophil antibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1992;33:668-74.
8. Oudkerk Pool M, Ellerbroek PM, Ridwan BU, et al. Serum antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease are mainly associated with ulcerative colitis. A correlation study between perinuclear antineutrophil cytoplasmic autoantibodies and clinical parameters, medical, and surgical treatment. Gut 1993;4:46-50.
9. Main J, McKenzie H, Yeaman GR, et al. Antibody to Saccharomyces cerevisiae (baker's yeast) in Crohn's disease. BMJ 1988;297:1105-6.
10. Barnes RMR, Allan S, Taylor-Robinson CH, et al. Serum antibodies reactive with Saccharomyces cerevisiae in inflammatory bowel disease. Is IgA antibody a marker for Crohn's disease? Int Arch Allergy Appl Immunol 1990;92:9-15.
11. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut 1992;33: 1071-5.
12. Sendid B, Colombel JF, Jacquinot PM, et al. Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diag Lab Immunol 1996;3:219-26.
13. Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index. Gastroenterology 1979;77:843-6.
14. Truelove SC, Witts LJ. Cortisone in ulcerative colitis. Final report on a therapeutic trial. BMJ 1955;2:1041-8.
15. Wiik A. Delineation of a standard procedure for immunofluorescence detection of ANCA. APMIS 1989;97(suppl 1):12-13.
16. Campbell G. Advances in statistical methodology for the evaluation of diagnostic and laboratory tests. Stat Med 1994;13:499-508.
17. Grenier B. Décision médicale, 1990:59-68.
18. Oudkerk Pool M, Roca M, Reumaux D, et al. The value of pANCA as a serological marker for ulcerative colitis in different European regions. Eur J Gastroenterol Hepatol 1994; 6:399-403.
19. Seidman EG, Ruemmele FM, Landers G, et al. Disease specificity diagnostic accuracy of new serological tests in pediatric IBD [abstract]. Gastroenterology 1997;112:A1087.
20. Yang H, Rotter JL. Genetics of inflammatory bowel disease. In: Targan SR, Shanahan F, eds. Inflammatory bowel disease. From bench to beside. Baltimore: Williams and Wilkins, 1994:32-64.
21. Reumaux D, Colombel JF, Delecourt L, et al. Antineutrophil cytoplasmic auto-antibodies (ANCA) in patients with ulcerative colitis: influence of disease activity and familial study. Acta Exp Med Biol 1993;336:515-18.
22. Reumaux D, Colombel JF, Duclos B, et al, and GETAID. Antineutrophil cytoplasmic auto-antibodies (ANCA) in sera with ulcerative colitis after proctocolectomy with ileoanal anastomosis. Adv Exp Med Biol 1993;336:523-5.
23. Vasiliauskas EA, Plevy SE, Landers CJ, et al. Perinuclear antineutrophil cytoplasmic antibodies in patients with Crohn's disease define a clinical subgroup. Gastroenterology 1996;110:1810-19.
24. Vasiliauskas EA, Plevy SE, Targan SR. Stratification of Crohn's disease by antineutrophil cytoplasmic antibodies (ANCA) and anti-Saccharomyces cerevisiae antibody (ASCA) distinguishes phenotypic subgroups [abstract]. Gastroenterology 1997;112:A1112.
25. Jamar-Leclerc N, Reumaux D, Duthilleul P, et al. Do pANCA define a clinical subgroup in patients with Crohn's disease [letter]? Gastroenterology 1997;112:316.
26. Vasiliauskas EA, Targan SR. Do pANCA define a clinical subgroup in patients with Crohn's disease [reply]? Gastroenterology 1997;112:316-17.
27. Polito JM II, Childs B, Mellits ED, et al. Crohn's disease: influence of age at diagnosis on site and clinical type of disease. Gastroenterology 1996;111:580-6.
28. Colombel JF, Grandbastien B, Gower-Rousseau C, et al. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 1996;111:604-7.